Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1247 (LINC01247) is a member of the long intergenic non-coding RNAs (lincRNAs), which are autonomously transcribed, non-coding RNA molecules longer than 200 nucleotides that do not overlap with annotated coding genes[3][5]. LINC01247 does not encode a protein but may play roles in regulating gene expression, chromatin organization, or RNA stability, similar to other lincRNAs[3][5]. As of now, there is no evidence in major databases or literature that LINC01247 is associated with specific biological functions, disease states, or therapeutic targeting[1][3]. It is classified as a non-coding RNA gene, with its main feature being potential involvement in fine-tuning expression of neighboring genes and possibly participating in tissue-specific regulatory processes characteristic of the lincRNA class[5]. There are no reported drugs, biomarker utilities, or major safety concerns related to LINC01247 at this time.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1247 (LINC01247).